ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3053; 2) Community: the network communities that were significantly associated with the response to NSC 3053; 3) Molecule: the relationships between components within communities and NSC 3053; 4) MDR: the compounds that were significantly associated with the NSC 3053.

NSC Compound Enrichment Correlation
NSC 679516 Null 0.000649370174092106 0.20167777
NSC 681972 Null 0.000649370174092106 0.4289963
NSC 718781 Erlotinib hydrochloride 0.000649370174092106 -0.42668081
NSC 725098 Null 0.000649370174092106 0.20234787
NSC 753456 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole 0.000649370174092106 0.1976257
NSC 753598 Null 0.000649370174092106 0.16064744
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.000649370174092106 0.25966125
NSC 132275 Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) 0.000710545569439728 0.571189
NSC 319947 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)-6-ethyl- 0.000710545569439728 0.35831168
NSC 357777 Null 0.000710545569439728 0.45890405
Total:171  Current:11    [First] [Prev] [Next] [Last]